BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35992153)

  • 1. Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status.
    Chen WC; Chou CK; Chang YH; Chiang PL; Lim LS; Chi SY; Luo SD; Lin WC
    Front Endocrinol (Lausanne); 2022; 13():933931. PubMed ID: 35992153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
    Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
    Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
    Chung SR; Baek JH; Choi YJ; Lee JH
    Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of radiofrequency ablation for recurrent thyroid cancer invading the airways.
    Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Eur Radiol; 2021 Apr; 31(4):2153-2160. PubMed ID: 32945966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis.
    Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS
    Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan.
    Lim LS; Lin WC; Chiang PL; Huang SC; Chen YS; Chang YH; Chen WC; Chi SY; Chou CK
    J Formos Med Assoc; 2022 Aug; 121(8):1406-1413. PubMed ID: 34657768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
    Yoo RE; Kim JH; Paeng JC; Park YJ
    Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
    Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
    Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Calcification on the Ultrasound-Guided Radiofrequency Ablation of Papillary Thyroid Carcinoma].
    Li YM; Yan L; Xiao J; Zhang MB; Luo YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):803-808. PubMed ID: 37927021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
    Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
    Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
    Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
    Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
    Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-Analysis of the Application Effect of Different Modalities of Thermal Ablation and Surgical Treatment in Papillary Thyroid Microcarcinoma.
    Li T; Lu B; Zhang Y; Sun Y
    Dis Markers; 2022; 2022():9714140. PubMed ID: 36217504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency Ablation for Cervical Metastatic Lymph Nodes in Children and Adolescents With Papillary Thyroid Carcinoma: A Preliminary Study.
    Yan L; Zhang Y; Jiang B; Luo Y
    Front Endocrinol (Lausanne); 2021; 12():624054. PubMed ID: 34084150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
    Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
    Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
    Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
    Tong M; Wang L; Gai Z; Zhu Y; Che Y
    Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term Outcome of T1bN0M0 Papillary Thyroid Cancer after Ultrasonography-guided Radiofrequency Ablation].
    Xiao J; Lan Y; Yan L; Zhang MB; Zhang Y; Xie F; Song Q; Luo YK; Tang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):771-775. PubMed ID: 33423724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma.
    Yan L; Zhang M; Song Q; Xiao J; Zhang Y; Luo Y
    Front Endocrinol (Lausanne); 2021; 12():663636. PubMed ID: 34177804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.